FDA Approved: IMVEXXY — Supplemental Application (Mayne Pharma LLC)

View source ↗

Summary

The FDA approved a supplemental application for IMVEXXY (estradiol) submitted by Mayne Pharma LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genitourinary Syndrome of Menopause
• Vulvar and Vaginal Atrophy Due to Menopause

Drugs mentioned

• IMVEXXY (Estradiol)

Snippet

SUPPL AP for IMVEXXY (ESTRADIOL)